title: Editorial: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources?
authors.forename: Phil
authors.initials: P
authors.lastname: Skolnick
authors.forename: David
authors.initials: D
authors.lastname: White
authors.affiliation: National Institute on Drug Abuse National Institutes of Health Bethesda, MD 20892 USA. jacri@nida.nih.gov.
authors.forename: Jane B
authors.initials: JB
authors.lastname: Acri
mesh_terms: D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D006801:Humans; D019966:Substance-Related Disorders / Q000209:etiology* / Q000628:therapy*
chemical_list: D000697:Central Nervous System Stimulants